Loading the records…
Loading the records…

Byron Donalds (R-FL) sold $1,0001 - $15,000 of $DT (Dynatrace, Inc. Common Stock (DT)) on Mar 27, 2024, part of 8 transactions in this filing (2 buys, 6 sells).
How the largest positions have moved from the trade date to the most recent close.
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $SNPS | Synopsys, Inc. Common Stock (SNPS)(Common Stock) | $1,0001 - $15,000 | $573.35 | $486.76 | -15.1% | Mar 27, 2024 |
| BUY | $SNPS | Synopsys, Inc. Common Stock (SNPS)(Common Stock) | $1,0001 - $15,000 | $573.35 | $486.76 | -15.1% | Mar 27, 2024 |
| SELL | $DT | Dynatrace, Inc. Common Stock (DT)(Common Stock) | $1,0001 - $15,000 | — | $39.69 | — | Mar 27, 2024 |
| SELL | $HUM | Humana Inc. Common Stock (HUM)(Common Stock) | $1,0001 - $15,000 | — | $308.43 | — | Mar 27, 2024 |
| SELL | $SONY | Sony Group Corporation American Depository Shares (SONY)(American Depository Shares) | $1,0001 - $15,000 | $17.31 | $22.61 | +30.6% | Mar 27, 2024 |
| SELL | $DT | Dynatrace, Inc. Common Stock (DT)(Common Stock) | $1,0001 - $15,000 | — | $39.69 | — | Mar 27, 2024 |
| SELL | $HUM | Humana Inc. Common Stock (HUM)(Common Stock) | $1,0001 - $15,000 | — | $308.43 | — | Mar 27, 2024 |
| SELL | $SONY | Sony Group Corporation American Depository Shares (SONY)(American Depository Shares) | $1,0001 - $15,000 | $17.31 | $22.61 | +30.6% | Mar 27, 2024 |
These bills and contracts share tickers or sectors with this filing's trades.
The Living Donor Protection Act of 2025 (S.1552), reported favorably out of committee and on the Senate calendar, prohibits life, disability, and long-term care insurers from discriminating against living organ donors. This removes an underwriting barrier, expands the insured pool, and drives increased transplant volume. Major managed care and insurance stocks have rallied 9-39% in the last 30 days, with this legislation providing a structural tailwind for revenue growth across the sector.
HR7861 (Care Over Profits Act) proposes raising the minimum MLR from 80% to 85% for individual/small group health plans. The bill is early-stage, referred to committee, and faces long odds, with only one cosponsor and no companion in the Senate. Despite the bearish direct impact on insurer margins, major health insurer stocks have rallied 7-40% over the past 30 days, indicating the market is not pricing in legislative risk.
HR8129, a bill to create a permanent full risk ACO program in traditional Medicare, is at early legislative stage with low momentum (1 cosponsor, 2 committees). Despite this, the four largest Medicare Advantage insurers ($UNH, $HUM, $CNC, $CVS) have already rallied sharply over 30 days — $CNC +62.34%, $HUM +38.49%, $UNH +35.85%, $CVS +16.05% — indicating investors are pricing in the structural shift to value-based care regardless of this specific bill's passage timeline.
HR8163 (Provider Reimbursement Stability Act) is an early-stage procedural bill that reduces physician fee cut frequency under Medicare budget neutrality rules, directly benefiting Medicare Advantage insurers. $UNH, $CVS, and $HUM have rallied 3-12% in the past week on bipartisan momentum signals, though zero authorized funding means zero direct revenue impact—only regulatory relief.
The Dental Care for Veterans Act (HR210) expands VA dental eligibility to all enrolled veterans, creating an estimated $5-10B annual procurement opportunity for dental suppliers. The bill has 95 cosponsors and passed committee hearings but no appropriations are authorized. HSIC and XRAY are the strongest structural beneficiaries given their pure-play dental exposure.
HR7860 (Stop ACA Enrollment Fraud Act) is a procedural early-stage bill that directly addresses fraudulent ACA enrollments through mandatory SSN deduplication and agent consent. The four major publicly traded ACA insurers — UnitedHealth, Humana, Cigna, and CVS Health — all stand to benefit from reduced fraud-driven administrative costs, though the bill is still in committee and passage is uncertain.
S.4027 bans anti-steering, all-or-nothing, and most-favored-nation contract clauses that hospital systems use to block insurers from directing patients to lower-cost providers. The market has already priced in momentum: $CI +3.7%, $HUM +12.5%, $CVS +6.4% in the past 7 days. Bill is in early stages (referred to HELP Committee) with no spending authorized — the mechanism is pure regulatory leverage shift from hospitals to insurers.
The National Programmable Cloud Laboratories Network Act (S.3468) has cleared committee and awaits floor action. The bill authorizes a new NSF-led network of AI-enabled, remotely programmable physical laboratories that will directly increase federal procurement of cloud infrastructure and EDA software. Major cloud providers (AMZN, MSFT, GOOGL) and semiconductor design tool vendors (SNPS, CDNS) are structural beneficiaries. The bill authorizes no specific dollar amount but establishes a program that requires significant ongoing procurement across multiple federal budget cycles.
HR8095 is a narrow technical fix allowing federal Medicaid payments for children in foster care placed in qualified residential treatment programs. The bill authorizes zero funding and is at an early legislative stage (referred to committee). Recent rallies in Medicaid MCO stocks like CNC (+62.37% 30-day) and MOH (+46.63% 30-day) are driven by broader sector dynamics, not this niche bill.
HR7884 (Healthcare is Human Act of 2026) is an early-stage House bill offering a modest tax credit to healthcare professionals for increased service hours in qualifying facilities. The bill has no appropriation, one cosponsor, and remains in committee. Real market data shows significant bullish movement in healthcare stocks $CVS (+6.65% 7-day, +15.73% 30-day) and $HUM (+12.64% 7-day, +39.82% 30-day) driven by unrelated sector fundamentals, not this legislation. No actionable market impact currently exists from this bill.
Free — no credit card
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.